blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4149928

EP4149928 - IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  17.02.2023
Database last updated on 19.10.2024
FormerThe international publication has been made
Status updated on  19.11.2021
Most recent event   Tooltip22.05.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Metabomed Ltd
18 HaKishon St
81220 Yavne / IL
[2023/12]
Inventor(s)01 / NAKACHE, Philippe
7401450 Ness Ziona / IL
02 / EREZ, Omri
7631003 Rehovot / IL
03 / BOTTI, Simone
7630242 Rehovot / IL
04 / GOUTOPOULOS, Andreas
Boston, Massachusetts, 02118 / US
05 / FINCH, Harry
Corner Haynes, Bedfordshire MK45 3QQ / GB
 [2023/12]
Representative(s)Dehns
10 Old Bailey
London EC4M 7NG / GB
[N/P]
Former [2023/12]Pearl Cohen Zedek Latzer Baratz UK LLP
The Gridiron Building
One Pancras Square
London N1C 4AG / GB
Application number, filing date21803230.812.05.2021
[2023/12]
WO2021IL50541
Priority number, dateWO2020IL5052414.05.2020         Original published format: PCT/IL2020/050524
[2023/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021229571
Date:18.11.2021
Language:EN
[2021/46]
Type: A1 Application with search report 
No.:EP4149928
Date:22.03.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 18.11.2021 takes the place of the publication of the European patent application.
[2023/12]
Search report(s)International search report - published on:IL18.11.2021
(Supplementary) European search report - dispatched on:EP13.05.2024
ClassificationIPC:C07D233/90, C07D401/10, C07D401/04, C07D413/10, C07D413/12, A61K31/4164, A61K31/4178, A61K31/4439, A61K31/506, A61K31/501, A61K31/497, A61K31/5377, A61K31/496, A61K31/454, A61P35/00, A61P25/32, A61P31/12, A61P1/16, A61P3/00, A61P25/00, A61P25/18
[2023/12]
CPC:
A61K45/06 (EP,IL,US); C07D401/10 (EP,IL,KR,US); C07D231/22 (EP,IL,US);
A61K31/4152 (US); A61K31/4155 (US); A61K31/4184 (US);
A61K31/422 (US); A61K31/427 (US); A61K31/4439 (KR,US);
A61K31/454 (US); A61K31/497 (KR,US); A61K31/501 (KR);
A61K31/506 (KR,US); A61K31/5377 (KR); A61P1/16 (EP,IL,KR);
A61P25/00 (EP,IL,KR,US); A61P25/18 (EP,IL); A61P25/24 (EP,IL);
A61P25/32 (EP,IL,KR); A61P29/00 (EP,IL,KR,US); A61P3/00 (EP,IL,KR,US);
A61P31/12 (EP,IL,KR,US); A61P35/00 (EP,IL,KR,US); A61P37/00 (EP,IL,KR);
A61P37/02 (US); C07D207/34 (EP,IL); C07D207/36 (EP,IL);
C07D213/81 (EP,IL); C07D231/14 (EP,IL); C07D231/16 (EP,IL);
C07D231/20 (US); C07D231/26 (EP,IL,US); C07D231/38 (EP,IL);
C07D231/46 (EP,IL); C07D233/70 (KR,US); C07D233/90 (EP,IL);
C07D239/28 (EP,IL); C07D241/24 (EP,IL); C07D249/06 (EP,IL);
C07D263/34 (EP,IL); C07D401/04 (EP,IL,KR,US); C07D401/12 (EP,IL,US);
C07D401/14 (EP,IL,US); C07D403/04 (EP,IL,US); C07D403/10 (EP,IL,KR,US);
C07D403/12 (KR,US); C07D405/04 (US); C07D405/10 (EP,IL,US);
C07D405/12 (KR,US); C07D405/14 (US); C07D409/04 (US);
C07D409/12 (US); C07D413/04 (EP,IL); C07D413/10 (EP,IL,US);
C07D413/12 (KR,US); C07D413/14 (US); C07D417/12 (US);
C07F5/025 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/12]
TitleGerman:AUF IMIDAZOL-3-OXIDDERIVAT BASIERENDE ACSS2-INHIBITOREN UND VERFAHREN ZUR VERWENDUNG DAVON[2023/12]
English:IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF[2023/12]
French:INHIBITEURS D'ACSS2 À BASE DE DÉRIVÉ DE 3-OXYDE D'IMIDAZOLE ET LEURS MÉTHODES D'UTILISATION[2023/12]
Entry into regional phase08.12.2022National basic fee paid 
08.12.2022Search fee paid 
08.12.2022Designation fee(s) paid 
08.12.2022Examination fee paid 
Examination procedure08.12.2022Amendment by applicant (claims and/or description)
08.12.2022Examination requested  [2023/12]
Fees paidRenewal fee
08.12.2022Renewal fee patent year 03
21.05.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0027823  (BLACK JAMES FOUNDATION [GB], et al)
International search[X]DE2324893  (HOECHST AG);
 [X]DD140966  (CREUZBURG DOERTHE, et al);
 [A]WO2015175845  (PELOTON THERAPEUTICS INC [US]);
 [X]US2017190689  (SPARKS RICHARD B [US], et al);
 [A]WO2019067528  (UNIV PENNSYLVANIA [US]);
 [Y]WO2019097515  (METABOMED LTD [IL]);
 [Y]US2019263758  (NAKACHE PHILIPPE [IL], et al);
 [XP]WO2020230134  (METABOMED LTD [IL]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.